SCHEMBL6977677

SCHEMBL6977677

COC(=O)C(NC(=O)c1cccnc1Cl)=C(Br)c1ccc(NC(=O)c2c(Cl)cncc2Cl)cc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 5/20 0.58
ITGA4 P13612 5/20 0.58
HTT P42858 2/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 3/20 0.42
RAB9A P51151 3/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 2/20 0.40
ATM Q13315 1/20 0.40
LMNA P02545 1/20 0.39
NR2E3 Q9Y5X4 1/20 0.38
POLB P06746 1/20 0.38
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6977675 1.00 ITGB1 (0.58) ITGB1ITGA4HTTMEN1KMT2A
SCHEMBL6963937 0.89 ITGB1 (0.60) ITGB1ITGA4HTTMEN1KMT2A
SCHEMBL6963934 0.89 ITGB1 (0.60) ITGB1ITGA4HTTMEN1KMT2A
SCHEMBL6972201 0.82 ITGB1 (0.66) ITGB1ITGA4HTTMEN1KMT2A
SCHEMBL6972192 0.82 ITGB1 (0.66) ITGB1ITGA4HTTMEN1KMT2A
SCHEMBL6977320 0.81 ITGB1 (0.67) ITGB1ITGA4HTTMEN1KMT2A
SCHEMBL6977318 0.81 ITGB1 (0.67) ITGB1ITGA4HTTMEN1KMT2A
SCHEMBL6512426 0.74 ITGB1 (0.53) ITGB1ITGA4HTTMEN1KMT2A
SCHEMBL6512435 0.72 ITGB1 (0.57) ITGB1ITGA4HTTMEN1KMT2A
SCHEMBL6514009 0.70 ITGB1 (0.58) ITGB1ITGA4HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1095036-B1 CINNAMIC ACID DERIVATIVES AS CELL ADHESION MOLECULES CELLTECH THERAPEUTICS LTD (GB) 2003-05-07 EP disclosed
US-6465471-B1 INHIBIT BINDING OF ALPHA 4 INTEGRINS TO THEIR LIGANDS THUS THEY ARE OF USE IN PROPHYLAXIS AND TREATMENT OF IMMUNE OR INFLAMMATORY DISORDERS CELLTECH THERAPEUTICS LIMITED (GB) 2002-10-15 US disclosed